We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

21 hedge funds and large institutions have $6.65M invested in Minerva Neurosciences in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $5.42M → $6.65M (+$1.24M)

0% more funds holding

Funds holding: 21 → 21 (0)

0.19% less ownership

Funds ownership: 30.04% → 29.85% (-0.19%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.82K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.47K
3
UOC
UBS O'Connor
Illinois
+$574
4
Bank of America
Bank of America
North Carolina
+$119

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$27.3K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$12.8K
3
TRCT
Tower Research Capital (TRC)
New York
-$4.48K
4
Wells Fargo
Wells Fargo
California
-$2.83K
5
Northern Trust
Northern Trust
Illinois
-$100
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$4.31M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$804K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$535K -$27.3K -10,065 -6%
UOC
4
UBS O'Connor
Illinois
$319K +$574 +212 +0.2%
BlackRock
5
BlackRock
New York
$232K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$176K +$6.82K +2,519 +5%
Northern Trust
7
Northern Trust
Illinois
$73.5K -$100 -37 -0.2%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$55K – – –
State Street
9
State Street
Massachusetts
$52.7K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$38.1K -$12.8K -4,743 -28%
Morgan Stanley
11
Morgan Stanley
New York
$34.3K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$7.81K -$4.48K -1,655 -40%
Wells Fargo
13
Wells Fargo
California
$6.18K -$2.83K -1,043 -35%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$6K +$3.47K +1,280 +233%
Russell Investments Group
15
Russell Investments Group
United Kingdom
$3.75K – – –
TFM
16
TFC Financial Management
Massachusetts
$594 – – –
Bank of America
17
Bank of America
North Carolina
$539 +$119 +44 +35%
Northwestern Mutual Wealth Management
18
Northwestern Mutual Wealth Management
Wisconsin
$319 – – –
SSB
19
Sandy Spring Bank
Maryland
$319 – – –
AIM
20
Anchor Investment Management
South Carolina
$38 – – –
UBS Group
21
UBS Group
Switzerland
$32 – – –

NERV Hedge Fund Activity: Q2 2024 in Review

21 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2024, worth a combined $6.65M — up 23% from $5.42M a quarter earlier.

Fund positioning in NERV was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $6.82K. The largest seller was Renaissance Technologies, cutting an estimated $27.3K.

  • 21 institutional investors held Minerva Neurosciences (NERV) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $6.65M of Minerva Neurosciences stock for Q2 2024, up 23% quarter-over-quarter.
  • 0 funds opened new Minerva Neurosciences positions in Q2 2024 and 0 closed out.
  • The largest Minerva Neurosciences buyer in Q2 2024 was Geode Capital Management, an estimated $6.82K added.
  • The largest Minerva Neurosciences seller in Q2 2024 was Renaissance Technologies, an estimated $27.3K sold.

Based on aggregated 13F filings for Q2 2024.